What is the market price of pomalidomide in 2024?

Pomalidomide (Pomalidomide), as a highly effective immunomodulatory drug, has emerged in the medical field. Its mechanism of action is to promote the production of normal blood cells in the bone marrow and effectively destroy abnormal cells. Combination therapy with pomalidomide and dexamethasone becomes an important treatment option when patients with multiple myeloma develop resistance to lenalidomide and proteasome inhibitors such as bortezomib or carfilzomib, or do not achieve remission within 60 days of these treatments.

Pomalidomide also plays a key role in the treatment of AIDS-related Kaposi's sarcoma. Especially for patients with Kaposi's sarcoma who are ineffective with other treatments or who are HIV-negative, pomalidomide has shown its unique efficacy. Patients need to take the medication according to a 28-day cycle, taking it once a day. They can choose whether to take it with food according to personal circumstances, and this cycle can be repeated according to medical advice.

Through the unremitting efforts of the domestic scientific research team, pomalidomide has been successfully developed and launched in China, and has been included in my country's medical insurance system. Currently on the market, there are two main specifications: 1 mg 21 capsules and 4 mg 21 capsules for patients to choose from. The price of domestic pomalidomide is quite affordable, with each box priced at about 4,000 yuan.

At the same time, the price of overseas original research version of pomalidomide is relatively high, and the price of each box may exceed RMB 10,000. However, overseas markets also provide more economical generic drug options. For example, pomalidomide produced in Laos may cost only a few hundred yuan per box. Of course, this price will also fluctuate due to the impact of exchange rates. It is worth mentioning that whether it is domestic or foreign generic drugs, or foreign original drugs, they maintain a high degree of consistency in their drug ingredients, providing patients with diversified treatment options.